Sign inOpen the app
IP Lex · Indian IP case law

IP Case Law › Trade Marks › Emcure Pharmaceuticals Limited v. Emsure Pharmaceutical Priv…

Trade Marks Ragulika IP case note

Emcure Pharmaceuticals Limited v. Emsure Pharmaceutical Private Limited

CourtDelhi High Court
BenchHon'ble Ms. Justice Jyoti Singh
Case numberCS(COMM) 524/2025
Judgment date13 January 2026
IP categoryTrade Marks
PartiesEmcure Pharmaceuticals Limited (Plaintiff) v. Emsure Pharmaceutical Private Limited (Defendant)

Relevant Acts and provisions

Provisions considered: Trade Marks Act, 1999 (infringement; passing off); Commercial Courts Act, 2015

Brief facts

Emcure sued Emsure Pharmaceutical for using EMSURE as its mark and name for pharmaceutical business. The defendant did not contest and the suit proceeded ex parte.

Issues before the Court

Whether the plaintiff was entitled to a decree of permanent injunction and costs.

Court's findings

The Court decreed the suit in favour of the plaintiff and awarded costs under the Commercial Courts Act, 2015 and the Delhi High Court (Original Side) Rules, 2018 read with the IPD Rules, 2022.

Decision

Suit decreed with permanent injunction against use of EMSURE; plaintiff to file a bill of costs by 28 February 2026 for computation by the Taxing Officer; decree sheet to be drawn.

Key legal principle / ratio

Where a defendant adopts a name and mark closely resembling a pharmaceutical company's established mark and does not contest the suit, a permanent injunction and actual costs may be decreed.

Important paragraph references

Paras 18-20.

Important: This case note is a research summary only. It must be verified against the full judgment by a qualified lawyer, advocate or patent/trade mark attorney before any reliance. Do not rely on it as legal advice; Ragulika IP accepts no responsibility for its accuracy or for any action taken on it.

Keywords

Actual Costs EMCURE EMSURE Ex Parte Decree Permanent Injunction Pharmaceutical Trade Marks

Read the judgment

View judgment (court website)